Back to News
Market Impact: 0.15
Insmed CFO Sara Bonstein To Step Down
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Insmed said CFO Sara Bonstein has decided to step down and will remain in the role until October 30. The company provided no further details on the departure or a successor.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment
INSM-0.20
More News
- Insmed CFO Sara Bonstein to step down on October 30
- Why did Mattel stock surge 5% today?
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- Nvidia's $20 billion Groq deal faces lawsuit alleging startup's stockholders were shortchanged
- BTIG reiterates Vaxcyte stock rating on strong VAX-31 trial data
- Why is NeoGenomics stock sliding today?